Cannara Biotech Inc. (TSXV: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products with two mega facilities based in Québec announced that it has received final approval to graduate from the TSX Venture Exchange to the Toronto Stock Exchange. In connection with the uplisting, the company’s common shares will commence trading on the TSX at the opening of the market on March 2, 2026, under the trading symbol LOVE.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Trulieve reports Q4 and full year 2025 results with 60 per cent gross margin and record cash flow generation
2 | Curaleaf announces closing of $500 million private placement of 11.5 per cent senior secured notes due 2029
3 | Cannabix Technologies closes $700,000 non-brokered private placement
4 | Canopy Growth announces MTL Cannabis shareholder approval of acquisition
Top Cannabis Stocks Feb. 14 to Feb. 26, 2026
1. T.CURA | 5,709 views | Curaleaf Holdings Inc.
2. T.LABS | 2,454 views | Medipharm Labs Corp.
3. T.TLRY | 2,195 views | Tilray Brands Inc.
4. C.OGI | 1,440 views | Organigram Global Inc.
5. T.TGIF | 269 views | 1933 Industries Inc.
6. C.BLO | 244 views | Cannabix Technologies Inc.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
